The US FDA has lifted the clinical hold and cleared ACT’s Investigational New Drug (IND) application to (immediately) initiate a Phase I/II multicenter study Read more…
On Friday (7/30/10), GERN said the clinical hold on its application has been lifted. The FDA notification enables Geron to move forward with the world’s first clinical trial of a human embryonic stem cell (hESC)-based therapy in man. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.